3
|
Fraccaro C, Al-Lamee R, Tarantini G, Maisano F, Napodano M, Montorfano M, Frigo AC, Iliceto S, Gerosa G, Isabella G, Colombo A. Transcatheter Aortic Valve Implantation in Patients With Severe Left Ventricular Dysfunction. Circ Cardiovasc Interv 2012; 5:253-60. [DOI: 10.1161/circinterventions.111.964213] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Chiara Fraccaro
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Rasha Al-Lamee
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Giuseppe Tarantini
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Francesco Maisano
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Massimo Napodano
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Matteo Montorfano
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Anna Chiara Frigo
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Sabino Iliceto
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Gino Gerosa
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Giambattista Isabella
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| | - Antonio Colombo
- From the Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (C.F., G.T., M.N., S.I., G.I.); Department of Cardiology, San Raffaele Hospital, Milan, Italy (R.A.-L., M.M., A.C.); Cardiothoracic Surgery, San Raffaele Hospital, Milan, Italy (F.M.); Laboratory of Epidemiological Methods and Biostatistics, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy (A.C.F.); Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, Padova,
| |
Collapse
|
5
|
Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJM, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32:205-17. [PMID: 21216739 PMCID: PMC3021388 DOI: 10.1093/eurheartj/ehq406] [Citation(s) in RCA: 504] [Impact Index Per Article: 38.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
OBJECTIVES To propose standardized consensus definitions for important clinical endpoints in transcatheter aortic valve implantation (TAVI), investigations in an effort to improve the quality of clinical research and to enable meaningful comparisons between clinical trials. To make these consensus definitions accessible to all stakeholders in TAVI clinical research through a peer reviewed publication, on behalf of the public health. BACKGROUND Transcatheter aortic valve implantation may provide a worthwhile less invasive treatment in many patients with severe aortic stenosis and since its introduction to the medical community in 2002, there has been an explosive growth in procedures. The integration of TAVI into daily clinical practice should be guided by academic activities, which requires a harmonized and structured process for data collection, interpretation, and reporting during well-conducted clinical trials. METHODS AND RESULTS The Valve Academic Research Consortium established an independent collaboration between Academic Research organizations and specialty societies (cardiology and cardiac surgery) in the USA and Europe. Two meetings, in San Francisco, California (September 2009) and in Amsterdam, the Netherlands (December 2009), including key physician experts, and representatives from the US Food and Drug Administration (FDA) and device manufacturers, were focused on creating consistent endpoint definitions and consensus recommendations for implementation in TAVI clinical research programs. Important considerations in developing endpoint definitions included (i) respect for the historical legacy of surgical valve guidelines; (ii) identification of pathophysiological mechanisms associated with clinical events; (iii) emphasis on clinical relevance. Consensus criteria were developed for the following endpoints: mortality, myocardial infarction, stroke, bleeding, acute kidney injury, vascular complications, and prosthetic valve performance. Composite endpoints for TAVI safety and effectiveness were also recommended. CONCLUSION Although consensus criteria will invariably include certain arbitrary features, an organized multidisciplinary process to develop specific definitions for TAVI clinical research should provide consistency across studies that can facilitate the evaluation of this new important catheter-based therapy. The broadly based consensus endpoint definitions described in this document may be useful for regulatory and clinical trial purposes.
Collapse
Affiliation(s)
- Martin B Leon
- Columbia University Medical Center, Center for Interventional Vascular Therapy, 173 Fort Washington Avenue, Heart Center, New York, NY 10032, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|